News room - Egetis Therapeutics

5 October, 2020 PledPharma carries out a fully guaranteed rights issue of approximately SEK 200 million in connection with the acquisition of Rare Thyroid Therapeutics News Corporate Action Shares Issuance English Regulatory MAR IR Optional

5 October, 2020 PledPharma to acquire Rare Thyroid Therapeutics, creating a new focused orphan drug development company News Corporate Action M&A English Regulatory MAR IR Optional

20 August, 2020 Half-Year report January-June 2020 News English Regulatory MAR VPML Report Interim Q2 IR Optional

30 July, 2020 Changes in PledPharma’s Board of Directors and committees News Corporate Information Staff change English Regulatory Listing Regulation IR Optional

9 July, 2020 Positive pre-clinical results with PledOx published in Antioxidants News Corporate Information Other Corporate Information English IR Optional mfn-cus-pledox

26 June, 2020 Positive pre-clinical results with PledOx to be presented at Peripheral Nerve Society’s annual meeting News Corporate Information Other Corporate Information English IR Optional

24 June, 2020 Marie-Louise Alamaa appointed interim CFO at PledPharma News Corporate Information Staff change English Regulatory Listing Regulation IR Optional

26 May, 2020 CFO Yilmaz Mahshid leaves PledPharma News Corporate Information Staff change English Regulatory Listing Regulation IR Optional

11 May, 2020 PledPharma receives US patent for method of treatment related to calmangafodipir News Corporate Information Other Corporate Information English IR Optional

23 April, 2020 Kommuniké från årsstämman i PledPharma AB (publ) News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR Optional

22 April, 2020 Interim report January-March 2020 News English Regulatory MAR Report Interim Q1 IR Optional

6 April, 2020 PledPharma to close POLAR phase 3 program in the third quarter News Corporate Action Other English Regulatory MAR IR Optional

2 April, 2020 Information on the Annual General Meeting and Covid-19 News Corporate Information Other Corporate Information English IR Optional

30 March, 2020 PledPharma’s 2019 annual report published News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR Optional

25 March, 2020 KALLELSE TILL ÅRSSTÄMMA I PLEDPHARMA AB News Corporate Information General meeting Notice English Regulatory Listing Regulation IR Optional

1 March, 2020 PledPharma places dosing of patients in the POLAR program on hold News Corporate Information Other Corporate Information English Regulatory MAR IR Optional mfn-cus-pledox

18 February, 2020 Year-end report January-December 2019 News English Regulatory MAR Report Interim Yearend IR Optional

23 January, 2020 PledPharma provides update on the clinical POLAR program, clinical hold in the US News Corporate Information Other Corporate Information English Regulatory MAR IR Optional mfn-cus-pledox

8 January, 2020 PledPharma to initiate one pivotal Phase II/III study with Aladote® for marketing authorisation application in both US and EU News Corporate Information Other Corporate Information English IR Optional mfn-cus-aladote

16 December, 2019 Global phase III study POLAR-A fully recruited News Corporate Information Other Corporate Information English IR Optional mfn-cus-pledox

10 December, 2019 PLEDPHARMA’S ASIAN PARTNER SOLASIA ENTERS AGREEMENT WITH JAPANESE MARUHO FOR COMMERCIALIZATION OF PLEDOX® News Corporate Information Other Corporate Information English IR Optional mfn-cus-pledox

31 October, 2019 Trading in PledPharma's shares commences today on the Nasdaq Stockholm main market News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR Optional

29 October, 2019 PledPharma publishes prospectus in connection with the list change to Nasdaq Stockholm’s main market News Corporate Action Prospectus English Regulatory Listing Regulation IR Optional

23 October, 2019 Interim report January-September 2019 News English Regulatory MAR Report Interim Q3 IR Optional

21 October, 2019 Nomination Committee appointed for the 2020 Annual General Meeting in PledPharma News Corporate Information Nomination Committee English Regulatory Listing Regulation IR Optional

Press releases

2020

2019

Calendar and upcoming reports

Contact us

Press releases

2020

2019

Calendar and upcoming reports

Subscribe

Contact us